Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2014 1
2017 1
2019 3
2020 5
2021 4
2022 4
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer.
Ogusu S, Harutani Y, Tozuka T, Saito R, Koyama J, Sakamoto H, Sonoda T, Tsuchiya-Kawano Y, Oba T, Kudo K, Gyotoku H, Nakatomi K, Ariyasu R. Ogusu S, et al. Among authors: gyotoku h. Cancer Immunol Immunother. 2023 Nov;72(11):3765-3772. doi: 10.1007/s00262-023-03528-x. Epub 2023 Aug 28. Cancer Immunol Immunother. 2023. PMID: 37638979 Free PMC article.
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study.
Yamada T, Goto Y, Tanaka H, Kimura H, Minato K, Gyotoku H, Honda T, Watanabe S, Morimoto K, Kiyomi F, Uchino J, Takayama K. Yamada T, et al. Among authors: gyotoku h. Eur J Cancer. 2023 Dec;195:113373. doi: 10.1016/j.ejca.2023.113373. Epub 2023 Oct 22. Eur J Cancer. 2023. PMID: 37890349 Free article. Clinical Trial.
Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets.
Shimada M, Taniguchi H, Yamaguchi H, Gyotoku H, Sasaki D, Kaku N, Senju C, Senju H, Imamura E, Takemoto S, Yamamoto K, Sakamoto N, Obase Y, Tsuchiya T, Fukuda M, Soda H, Ashizawa K, Fukuoka J, Nagayasu T, Yanagihara K, Mukae H. Shimada M, et al. Among authors: gyotoku h. Transl Lung Cancer Res. 2023 Apr 28;12(4):707-718. doi: 10.21037/tlcr-22-794. Epub 2023 Mar 23. Transl Lung Cancer Res. 2023. PMID: 37197618 Free PMC article.
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.
Tomono H, Taniguchi H, Fukuda M, Ikeda T, Nagashima S, Akagi K, Ono S, Umeyama Y, Shimada M, Gyotoku H, Takemoto S, Hisamatsu Y, Morinaga R, Tagawa R, Ogata R, Dotsu Y, Senju H, Soda H, Nakatomi K, Hayashi F, Sugasaki N, Kinoshita A, Mukae H. Tomono H, et al. Among authors: gyotoku h. Thorac Cancer. 2023 Oct;14(28):2890-2894. doi: 10.1111/1759-7714.15097. Epub 2023 Sep 7. Thorac Cancer. 2023. PMID: 37675546 Free PMC article.
[Trends in Outpatient Chemotherapy for Thoracic Oncology].
Fukuda M, Yamaguchi H, Takemoto S, Senju H, Gyotoku H, Dotsu Y, Umeyama Y, Tsuchiya A, Ikeda T, Nose S, Honda T, Kobayashi K, Ishii K, Mukae H, Ashizawa K. Fukuda M, et al. Among authors: gyotoku h. Gan To Kagaku Ryoho. 2020 Oct;47(10):1461-1464. Gan To Kagaku Ryoho. 2020. PMID: 33130741 Japanese.
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy.
Takemoto S, Ozasa M, Mizuta R, Tagawa R, Ono S, Honda N, Suyama T, Umeyama Y, Dotsu Y, Gyotoku H, Yamaguchi H, Yamamoto K, Sakamoto N, Obase Y, Fukuda M, Mukae H. Takemoto S, et al. Among authors: gyotoku h. Lung Cancer Manag. 2023 Mar 27;11(4):LMT57. doi: 10.2217/lmt-2022-0001. eCollection 2022 Dec. Lung Cancer Manag. 2023. PMID: 37284227 Free PMC article.
26 results